Abstract Purpose Manufacturing processes for polypeptide/protein drugs are designed to ensure robust quality, efficacy and safety
Food and Drug Administration (2023) Tirzepatide versus semaglutide once weekly in patients with Type 2 diabetes, The New England Journal of Medicine (2021) Johns Hopkins scientists say risk of pancreatitis doubles for those taking new class of diabetes drugs, John Hopkins Medicine (2013) Normal and disordered gastric emptying in diabetes: Recent insights into (patho)physiology, management and impact on glycaemic control, Diabetologia (2022) GLP-1 receptor agonists and the risk of thyroid cancer, American Diabetes Association (2022) Mounjaro highlights of prescribing information, The U.S
What happens if I stop Mounjaro
Results from the SURPASS program's phase 3 trials indicate that tirzepatide, administered weekly in doses of 5mg, 10mg, and 15mg, significantly enhances glycemic control in T2D
During the injection Clean with alcohol, then wait
Check out more information through tirzepatide clinic care